Browsing: Psychedelics
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
By admin
The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable…
Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company – Bright Green (NASDAQ:BGXX)
By admin
Bright Green Corporation BGXX has signed a letter of intent (LOI) to supply its DEA-approved cannabis extracts and plant-based psychedelics…
A national drug policy reform organization is challenging the DEA’s proposal to ban two psychedelic substances, arguing the move would…